Shionogi & Co Ltd  

(Public, TYO:4507)   Watch this stock  
Find more results for 4507
5,658.00
+26.00 (0.46%)
Delayed:   10:27AM GMT+9
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 5,599.00 - 5,665.00
52 week 4,537.00 - 6,433.00
Open 5,600.00
Vol. 264,700.00
Mkt cap 1.86T
P/E 21.13
Div/yield 38.00/1.27
EPS 267.76
Shares 318.79M
Beta     -
Inst. own     -
Oct 30, 2017
Q2 2018 Shionogi & Co Ltd Earnings Release (Estimated) Add to calendar
Jul 31, 2017
Q1 2018 Shionogi & Co Ltd Earnings Release
Jul 31, 2017
Q1 2018 Shionogi & Co Ltd Earnings Call (Japanese)
Jul 31, 2017
Q1 2018 Shionogi & Co Ltd Earnings Call - Webcast
Jul 24, 2017
Shionogi & Co Ltd Top-Line Results for S-033188 Phase III Study in Otherwise Healthy Influenza Patients Conference Call
Jul 24, 2017
Shionogi & Co Ltd Top-Line Results for S-033188 Phase III Study in Otherwise Healthy Influenza Patients Conference Call (Japanese)
Jun 23, 2017
Shionogi & Co Ltd Annual Shareholders Meeting (Estimated)
Jun 22, 2017
Shionogi & Co Ltd Annual Shareholders Meeting
  

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin 21.36% 24.67%
Operating margin 20.61% 30.79%
EBITD margin - 36.74%
Return on average assets 9.69% 12.77%
Return on average equity 12.18% 16.25%
Employees 5,511 -
CDP Score - -

Address

3-1-8, Dosho-machi, Chuo-ku
OSAKA-SHI, OSK 541-0045
Japan
+81-6-62022161 (Phone)
+81-6-62299596 (Fax)

Website links

Description

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company. It is engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The Company mainly provides vitamin preparations, analgesic antipyretics, cold and sinus medicine, digestive medicine, dermatologic preparations, antiphlogistic analgetics, antihypercholesterolemic agents, test paper for glucose in urine and artificial teeth-related products. As of March 31, 2014, the Company had 37 subsidiaries and six associated companies.

Officers and directors

Motozo Shiono Chairman of the Board, Representative Director
Age: 70
Isao Teshirogi President, Representative Director
Age: 57
Koji Hanasaki Senior Executive Officer, Director of Accounting & Finance
Takuko Sawada Senior Managing Executive Officer, Chief Director of Business Strategy, Director
Age: 62
Takuo Fukuda Senior Executive Officer
Yoshiaki Kamoya Senior Executive Officer
John Keller Senior Executive Officer
Ryuichi Kume Senior Executive Officer
Takayuki Yoshioka Senior Executive Officer
Kazuhiro Hatanaka Executive Officer